3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
3
OTHER_GOV
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Stomach Neoplasms
1
Interventions
Oxaliplatin
10
Fluorouracil
6
Irinotecan
5
Docetaxel
5
Capecitabine
5
tislelizumab
4
S 1 (combination)
4
Paclitaxel
4
Endoscopic Mucosal Resection
4
XELOX
3
Levoleucovorin
3
Laparoscopy
3
Folfox protocol
3
sintilimab
2
apatinib
2
Proton Pump Inhibitors
2
Gastroenterostomy
2
Gastrectomy
2
Clarithromycin
2
Chemotherapy, Adjuvant
2
Amoxicillin
2
vactosertib
1
titanium silicide
1
pembrolizumab
1
lenvatinib
1
durvalumab
1
bismuth tripotassium dicitrate
1
anlotinib
1
Trastuzumab
1
Tranexamic Acid
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER_GOV
×
Stomach Neoplasms
×
Anastomosis, Roux-en-Y
×
Clear all
NCT01257711
2021-03-09
SCAR
National Healthcare Group, Singapore
Phase NA
Completed
96 enrolled